Filtrovat podle Last updated date SelectpopředFrom - To Datum Datum ukončení Tento týden Tento měsíc Minulý týden Minulý měsíc Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationMedical devicesScientific adviceMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Leave this field blank Filter Výsledky (3794) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank EMA working on COVID-19 over holiday period 30 Březen 2021 News Corporate COVID-19 Increase in vaccine manufacturing capacity and supply for COVID-19 vaccines from AstraZeneca, BioNTech/Pfizer and Moderna 26 Březen 2021 News Human COVID-19 Vaccines EMA issues advice on use of regdanvimab for treating COVID-19 26 Březen 2021 News Human COVID-19 Medicines Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 March 2021 26 Březen 2021 News Human COVID-19 Generic and hybrid medicines Medicines Referrals COVID-19 Vaccine AstraZeneca – Update on ongoing evaluation of blood clot cases 25 Březen 2021 News Human COVID-19 Vaccines EMA advises against use of ivermectin for the prevention or treatment of COVID-19 outside randomised clinical trials 22 Březen 2021 News Human COVID-19 Medicines Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 16-18 March 2021 19 Březen 2021 News Veterinary Medicines COVID-19 Vaccine AstraZeneca: benefits still outweigh the risks despite possible link to rare blood clots with low blood platelets 19 Březen 2021 News Human COVID-19 Vaccines Investigation of COVID-19 Vaccine AstraZeneca and thromboembolic events continues 16 Březen 2021 News Human COVID-19 Vaccines EMA’s safety committee continues investigation of COVID-19 Vaccine AstraZeneca and thromboembolic events – further update 15 Březen 2021 News Human COVID-19 Vaccines 1 … 64 65 66 67 68 Page 68 of 380 69 70 71 72 … 380
Increase in vaccine manufacturing capacity and supply for COVID-19 vaccines from AstraZeneca, BioNTech/Pfizer and Moderna 26 Březen 2021 News Human COVID-19 Vaccines
EMA issues advice on use of regdanvimab for treating COVID-19 26 Březen 2021 News Human COVID-19 Medicines
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 March 2021 26 Březen 2021 News Human COVID-19 Generic and hybrid medicines Medicines Referrals
COVID-19 Vaccine AstraZeneca – Update on ongoing evaluation of blood clot cases 25 Březen 2021 News Human COVID-19 Vaccines
EMA advises against use of ivermectin for the prevention or treatment of COVID-19 outside randomised clinical trials 22 Březen 2021 News Human COVID-19 Medicines
Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 16-18 March 2021 19 Březen 2021 News Veterinary Medicines
COVID-19 Vaccine AstraZeneca: benefits still outweigh the risks despite possible link to rare blood clots with low blood platelets 19 Březen 2021 News Human COVID-19 Vaccines
Investigation of COVID-19 Vaccine AstraZeneca and thromboembolic events continues 16 Březen 2021 News Human COVID-19 Vaccines
EMA’s safety committee continues investigation of COVID-19 Vaccine AstraZeneca and thromboembolic events – further update 15 Březen 2021 News Human COVID-19 Vaccines